Company profile

Iovance Biotherapeutics, Inc.

Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.

Industry
Biotechnology Research
Employees
929
Headquarters
San Carlos, California
Founded
2007
LinkedIn followers
38,729
Office locations
5

Iovance Biotherapeutics, Inc. company summary

Iovance Biotherapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in San Carlos, California, founded in 2007. On LinkedIn the company has around 929 employees and 38,729 followers. The company lists 5 office locations. Its listed specialties include Immuno Oncology, Autologous Cell Therapy, Tumor Infiltrating Lymphocytes (TIL), Novel Cancer Immunotherapies, cell therapy.

What technology does Iovance Biotherapeutics, Inc. use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings

Specialties

Immuno OncologyAutologous Cell TherapyTumor Infiltrating Lymphocytes (TIL)Novel Cancer Immunotherapiescell therapy

Where is Iovance Biotherapeutics, Inc. located?

Iovance Biotherapeutics, Inc. lists 5 office locations.

San Carlos, California, USHQ
825 Industrial Rd
Amsterdam, North Holland, NL
Gustav Mahlerlaan 1212
Philadelphia, Pennsylvania, US
300 Rouse Blvd
Philadelphia, Pennsylvania, US
700 Spring Garden St
Tampa, Florida, US
3802 Spectrum Blvd

Compare companies similar to Iovance Biotherapeutics, Inc.

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Iovance Biotherapeutics, Inc.
iovance.com
Biotechnology Research9292007San Carlos, California
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Iovance Biotherapeutics, Inc.

What does Iovance Biotherapeutics, Inc. do?

Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida. Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings

How many employees does Iovance Biotherapeutics, Inc. have?

Iovance Biotherapeutics, Inc. has around 929 employees on LinkedIn.

Where is Iovance Biotherapeutics, Inc. headquartered?

Iovance Biotherapeutics, Inc. is headquartered in San Carlos, California.

Where does Iovance Biotherapeutics, Inc. have offices?

Iovance Biotherapeutics, Inc. lists 5 office locations, including San Carlos, California, US; Amsterdam, North Holland, NL; Philadelphia, Pennsylvania, US; Tampa, Florida, US.

When was Iovance Biotherapeutics, Inc. founded?

Iovance Biotherapeutics, Inc. was founded in 2007.

Build a lead list from companies like Iovance Biotherapeutics, Inc.

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.